Patient navigation and healthcare access among breast cancer patients undergoing radiotherapy.
Abstract
249 Background: Socioeconomic and structural barriers contribute to inequities in breast cancer radiotherapy (RT) access, completion, and patient experience. Patient navigation may improve care coordination by addressing logistical and psychosocial barriers during treatment. Methods: We conducted a prospective comparative analysis of pre- and post-RT survey data from patients enrolled in the multicenter Navigator-Assisted Hypofractionation (NAVAH) phase I trial. The pre-RT cohort included 44 patients with breast cancer. Post-RT analyses compared patients who electively received navigation services (Navigator, n=14) with those who did not (Non-Navigator, n=13). Outcomes included patient-reported healthcare access domains based on the 5 A’s framework, receipt of supportive services, and appointment adherence, defined as no missed appointments. Lower domain scores indicated more favorable outcomes. Results: The pre-RT cohort was predominantly low-income, with 89% reporting annual household income below $50,000 and 66% below $20,000. Transportation barriers were reported by 14%, though all patients had daily phone access and 86% had daily internet access. Baseline composite access scores were generally favorable, with 55% in the Good range and 30% in the Excellent range, but equity perceptions were mixed; 48% agreed that high-income patients receive better care than low-income patients. In post-RT analyses, navigated patients reported more favorable Accessibility (4.29 vs 5.38, p=0.02), Accommodation (30.64 vs 34.23, p=0.02), and Acceptability (11.00 vs 18.00, p<0.001) scores than non-navigated patients. Affordability scores did not significantly differ (10.79 vs 11.77, p=0.26), while Availability trended favorably among navigated patients (37.2 vs 46.8, p=0.05). Navigated patients more often reported travel-related financial assistance (50% vs 8%, p=0.03), any supportive services (57% vs 17%, p=0.06), and emotional support during treatment (50% vs 17%, p=0.06). Complete appointment attendance was higher in the Navigator group (92% vs 83%), but this difference was not statistically significant (p=0.50). Conclusions: In this early NAVAH cohort, patient navigation was associated with more favorable patient-reported healthcare access, particularly Accessibility, Accommodation, and Acceptability, and with greater receipt of travel-related financial assistance. Although appointment adherence was numerically higher among navigated patients, the difference was not statistically significant. These findings support continued evaluation of patient navigation as clinical infrastructure to improve care coordination and advance equity in breast cancer RT. Clinical trial information: 07014618 .